pharma news, views and analysis - pharmaphorum.com

Trending

in News
Pharming buys rare disease drug from Novartis for $20m
August 14, 2019 Share
X
Pharming buys rare disease drug from Novartis for $20m
https://pharmaphorum.com/news/pharming-buys-rare-disease-drug-from-novartis-for-20m/
in News
First effective Ebola treatment a step closer after breakthrough trial
August 13, 2019 Share
X
First effective Ebola treatment a step closer after breakthrough trial
https://pharmaphorum.com/news/ebola-virus-clinical-trial-breakthrough/

Latest News

US senators blast Novartis for Zolgensma data falsification

US senators blast Novartis for Zolgensma data falsification

US politicians have urged the FDA to come down hard on Novartis for failing to disclose manipulated data

X

US senators blast Novartis for Zolgensma data falsification

https://pharmaphorum.com/news/us-senators-blast-novartis-for-zolgensma-data-falsification/

Science sector lauds UK’s visa scheme, but repeats no-deal Brexit warning

Science sector lauds UK’s visa scheme, but repeats no-deal Brexit warning

Boris Johnson has ordered a new fast-track visa scheme to make it easier for top scientists to work

X

Science sector lauds UK’s visa scheme, but repeats no-deal Brexit warning

https://pharmaphorum.com/news/science-sector-lauds-uks-visa-scheme-but-repeats-no-deal-brexit-warning/

Bayer boosts cell therapy pipeline with BlueRock acquisition

Bayer boosts cell therapy pipeline with BlueRock acquisition

Bayer has announced it is fully acquiring US cell therapy biotech BlueRock Therapeutics, whose cell therapy pipeline includes

X

Bayer boosts cell therapy pipeline with BlueRock acquisition

https://pharmaphorum.com/news/bayer-boosts-cell-therapy-pipeline-with-bluerock-acquisition/

Views & Analysis

Sharing success to unlock the “triple win” of joint working

Sharing success to unlock the “triple win” of joint working

The fortunes of the NHS and the UK’s life sciences industry are intertwined, with each sector’s success or

X

Sharing success to unlock the “triple win” of joint working

https://pharmaphorum.com/r-d/views-analysis-r-d/sharing-success-to-unlock-the-triple-win-of-joint-working/

Bringing innovative trials to the UK

Bringing innovative trials to the UK

We spoke with the National Institute for Health Research’s (NIHR) senior business development manager, Anjna Rising, to learn

X

Bringing innovative trials to the UK

https://pharmaphorum.com/r-d/views-analysis-r-d/bringing-innovative-trials-to-the-uk/

Tackling the remaining challenges of multiple sclerosis

Tackling the remaining challenges of multiple sclerosis

With Merck KGaA’s multiple sclerosis drug evobrutinib entering phase 3 trials, we spoke to the company’s Fernando Dangond

X

Tackling the remaining challenges of multiple sclerosis

https://pharmaphorum.com/r-d/views-analysis-r-d/tackling-the-remaining-challenges-of-multiple-sclerosis/

Debates & Insights

Navigating new frontiers: Ways to find space in the future RA market

Navigating new frontiers: Ways to find space in the future RA market

Overview Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15

X

Navigating new frontiers: Ways to find space in the future RA market

https://pharmaphorum.com/r-d/navigating-new-frontiers-ways-to-find-space-in-the-future-ra-market/

Understanding blockchain – a practical guide for life sciences companies

Understanding blockchain – a practical guide for life sciences companies

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

X

Understanding blockchain – a practical guide for life sciences companies

https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/

Marketing science – brand innovation for pharma

Combining fields such as economics, statistics and operations research, marketing science has for some time operated under-the-radar as

X

Marketing science – brand innovation for pharma

https://pharmaphorum.com/debates-insight-sales-marketing/marketing-science-brand-innovation-for-pharma/

Partner Content

Your Ultimate Guide To The Skin Microbiome

Your Ultimate Guide To The Skin Microbiome

Your Ultimate Guide To The Skin Microbiome

X

Your Ultimate Guide To The Skin Microbiome

https://pharmaphorum.com/events/your-ultimate-guide-to-the-skin-microbiome/

Speaker Interview with iVeena Released for 3rd Ophthalmic Drugs Conference

Speaker Interview with iVeena Released for 3rd Ophthalmic Drugs Conference

Ophthalmic Drugs Conference Speaker Interview

X

Speaker Interview with iVeena Released for 3rd Ophthalmic Drugs Conference

https://pharmaphorum.com/partner-content/speaker-interview-with-iveena-released-for-3rd-ophthalmic-drugs-conference/

The Latest Innovations in HPAPI Manufacturing Technologies

The Latest Innovations in HPAPI Manufacturing Technologies

HPAPI Technologies

X

The Latest Innovations in HPAPI Manufacturing Technologies

https://pharmaphorum.com/partner-content/the-latest-innovations-in-hpapi-manufacturing-technologies/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com